DOI:
10.1039/C5RA15576B
(Paper)
RSC Adv., 2015,
5, 88809-88815
Structure modulation in zinc–ditetrazolate coordination polymers by in situ ligand synthesis†
Received
4th August 2015
, Accepted 14th October 2015
First published on 14th October 2015
Abstract
Three new ZnII–ditetrazolate coordination polymers (CPs), namely [Zn(m-pdtz)(4,4′-bipy)(H2O)]n (1), [Zn2Cl2(m-pdtz)(4,4′-bipy)]n (2) and [Zn2(OH)2(m-pdtz)]n (3) (4,4′-bipy = 4,4′-bipyridine, m-H2pdtz = 5,5′-1,3-phenylene-ditetrazole), have been constructed by an in situ ditetrazolate-ligand synthesis system. The formation of m-pdtz2- ligand involves the Sharpless [2 + 3] cycloaddition reaction between isophthalonitrile (IPN) and NaN3 in the presence of Zn2+ ions as Lewis-acid catalysts under hydro/solvothermal conditions. Single-crystal structural analyses reveal that compound 1 exhibits a new 6-connected 3D structural topology constructed from dimeric {Zn2} clusters as secondary building units (SBUs), compound 2 represents a 2D sql structural feature built from rhombic tetrameric {Zn4} rings as SBUs, while compound 3 displays a new (4,6)-connected 3D structural topology constructed from rod-shaped 1D Zn-chains as SBUs. Regarding these three CPs, we have performed a thorough investigation on their crystal structure, topology, and fluorescence property.
Introduction
The design and synthesis of coordination polymers (CPs) have stimulated the interest of chemists in recent years because of their charming architectures and potential applications in a variety of scientific fields like nanoscale magnetism,1 catalysis,2 gas storage and separation,3 drug delivery,4 and sensor devices.5 From a synthetic point of view, the judicious selection of appropriate organic ligands are proved to be one of the most critical factors to manipulate the versatile structures of CPs.6–10 Among multitudinous organic ligands, ditetrazolates-containing ligands, in particular, have proved to be good candidates for the construction of novel CPs due to their multidentate nature, which endows them flexible and diverse coordination modes.11 Specifically, the ditetrazolates with two tetra-N-donor can provide more coordination sites for metal centers to form complicated frameworks; however, the reports on this class of ligands to prepare new CPs have been far less explored.
Until now, current research mainly involves using two effective strategies to construct the CPs based on tetrazolate-containing ligands.11–15 The first and the most common strategy is ligand availability, which directly introduces tetrazolate-containing ligands into synthetic system, such as hydrothermal reactions or other conventional synthesis.11a–d,12,13 The use of available tetrazolate-containing ligands would consequently increase the possibility of coordination between organic ligands and metal ions, thus benefiting us to obtain splendid structures in target CPs. The appropriate tetrazolate-containing ligands can be artificially designed, synthesized and modified by the mature technique of organic synthesis. So this strategy has found wide applications and has been applied successfully in many examples of CPs.11a–d,12,13
The second strategy of achieving tetrazolate-based CPs is to construct the CPs from the famous in situ ligand synthesis system of Sharpless [2 + 3] cycloaddition reactions between cyano precursors and azide groups in a hydrothermal environment with various transition metal ions as the Lewis acid catalysts.11e–h,14,15 As references demonstrated, this method also suggests a preeminent route for the exploration of novel tetrazolate-based CPs. In contrast to the first strategy, this system can fabricate more fascinating structures because it has more potential factors to create, modulate or influence the structural diversities during the assembly process. Recently, this approach has also been successfully implemented to construct some wonderful CPs exhibiting interesting properties.11e–h,14,15
In addition, a careful selection of the different synthetic condition, such as metal–ligand ratio, solvent, and auxiliary ligand, is a key step for the effective design of CPs with specific structural modulation. In this paper, we want to adjust the metal coordination modes by changing the metal–ligand ratio in order to influence the dimensionality of the CPs. At the same time, we can change the solvent system to achieve the different nuclear degree of the metal. More important, we also introduce the auxiliary ligand, such as the rigid long chain-like N-donor 4,4′-bipy, to induce the potential structural transformations, mainly because of its propensity to form voids or frameworks structures.
In view of this, we draw lessons from the latter strategy and exploited in situ ditetrazolate-ligand synthesis of IPN, NaN3 and ZnCl2, which consequently led to the formation of three new CPs [Zn(m-pdtz)(4,4′-bipy)(H2O)]n (1), [Zn2Cl2(m-pdtz)(4,4′-bipy)]n (2) and [Zn2(OH)2(m-pdtz)]n (3). Herein, the formation of m-pdtz2− ligand involves the in situ Sharpless [2 + 3] cycloaddition reaction between IPN and NaN3 in the presence of Zn2+ ion as a Lewis-acid catalyst under hydro/solvothermal conditions.16 Among the resulting CPs, compound 1 exhibits a new 6-connected 3D structural topology constructed from dimeric {Zn2} clusters as SBUs (secondary building units), and compound 2 represents a 2D sql structural feature built from rhombic tetrameric {Zn4} rings as SBUs, while compound 3 displays a new (4,6)-connected 3D structural topology constructed from rod-shaped 1D Zn-chains as SBUs. In this work, both the crystal structures and topological analyses of CPs 1–3 have been investigated in detail, as well as the exploration of their fluorescence properties.
Experimental
Materials and methods
All chemicals were commercially purchased and used as received.
Elemental analyses (C, H and N) were performed on a Perkin-Elmer 240C analyzer (Perkin-Elmer, USA). The X-ray powder diffraction (XRPD) was recorded on a Rigaku D/Max-2500 diffractometer at 40 kV, 100 mA for a Cu-target tube and a graphite monochromator. Simulation of the XRPD spectra were carried out by the single-crystal data and diffraction-crystal module of the mercury (Hg) program available. IR spectrum was measured in the range of 400–4000 cm−1 on a Tensor 27 OPUS FT-IR spectrometer using KBr pellets (Bruker, German). Fluorescence spectra were recorded at room temperature on a Varian Cary Eclipse fluorescence spectrometer (Varian, USA). Fluorescence lifetime were measured on an Edinburgh Instruments FLS920P equipped with a Xe lamp-900 and μF920 as the excitation light source. Solid state UV-vis spectra were recorded at room temperature on a Varian Cary 5000 Spectrophotometer in the wavelength range of 200–800 nm.
Synthesis of CPs 1–3.
[Zn(m-pdtz)(4,4′-bipy)(H2O)]n (1). A mixture of ZnCl2 (68 mg, 0.5 mmol), IPN (38 mg, 0.3 mmol), NaN3 (65 mg, 1 mmol), 4,4′-bipy (47 mg, 0.3 mmol) and H2O (8 mL) were sealed in a 23 mL Teflon lined stainless steel container, which was heated at 160 °C for 3 days and then cooled to room temperature at a rate of 10 °C h−1. Colourless block shaped crystals of 1 were collected. Yield: 20% for 1 based on Zn. Elemental analysis (%) for 1, C18H14N10OZn (M = 451.78): calcd: 47.85; H, 3.12; N, 31.00; found: C, 47.92; H, 3.08; N, 31.04.
[Zn2Cl2(m-pdtz)(4,4′-bipy)]n (2). A mixture of ZnCl2 (136 mg, 1 mmol), IPN (38 mg, 0.3 mmol), NaN3 (65 mg, 1 mmol), 4,4′-bipy (47 mg, 0.3 mmol) and H2O (8 mL) were sealed in a 23 mL Teflon lined stainless steel container, which was heated at 160 °C for 3 days and then cooled to room temperature at a rate of 10 °C h−1. Colourless block shaped crystals of 2 were collected. Yield: 21% for 2 based on Zn. Elemental analysis (%) for 2, C18H12N10Cl2Zn2 (M = 570.08): calcd: C, 49.64; H, 4.57; N, 11.58; found: C, 49.67; H, 4.48; N, 11.63.
[Zn2(OH)2(m-pdtz)]n (3). A mixture of ZnCl2 (68 mg, 0.5 mmol), IPN (38 mg, 0.3 mmol), NaN3 (65 mg, 1 mmol), 1-H-tetrazole (21 mg, 0.3 mmol) and H2O/EtOH (8 mL, v
:
v = 1
:
1) were sealed in a 23 mL Teflon lined stainless steel container, which was heated at 160 °C for 3 days and then cooled to room temperature at a rate of 10 °C h−1. Colourless block shaped crystals of 3 were collected. Yield: 22% for 3 based on Zn. Elemental analysis (%) for 3, C8H6N8O2Zn2 (M = 377.00): calcd: C, 25.49; H, 1.60; N, 29.72; found: C, 25.56; H, 1.53; N, 29.75.
X-ray crystallography. The crystallographic data of 1, 2 and 3 were collected on a Rigaku SCX-mini diffractometer at 293(2) K with Mo-Kα radiation (λ = 0.71073 Å). The crystal data were solved by direct methods and refined by a full-matrix least-square method on F2 using the SHELXL-97 crystallographic software package.17 Zinc atoms in 1, 2 and 3 were found from E-maps and other non-hydrogen atoms were located in successive difference Fourier syntheses. The final refinement was performed by full matrix least-squares methods with anisotropic thermal parameters for non-hydrogen atoms on F2. The hydrogen atoms of organic ligands, OH− group and lattice water were added theoretically, riding on the concerned atoms and refined with fixed thermal factors. Further details of crystal data and structure refinement for 1, 2 and 3 were summarized as follows in Table 1. Selected bond lengths and angels of 1, 2 and 3 were given in Tables S2–S4.† Full crystallographic data for 1, 2 and 3 have been deposited with the CCDC (1407193 for 1, 1407194 for 2 and 1407195 for 3).†18
Table 1 Crystal data and structure refinements for 1–3
|
1 |
2 |
3 |
R1 = ∑(||F0| − |FC||)/∑|F0|. wR2 = [∑w(|F0|2 − |FC|2)2/(∑w|F0|2)2]1/2. |
Formula |
C18H14N10OZn |
C18H12Cl2N10Zn2 |
C8H6N8O2Zn2 |
CCDC no. |
1407193 |
1407194 |
1407194 |
Size (mm) |
0.20 × 0.18 × 0.18 |
0.22 × 0.17 × 0.16 |
0.22 × 0.18 × 0.16 |
Formula weight |
451.78 |
570.08 |
377.00 |
Crystal system |
Monoclinic |
Triclinic |
Monoclinic |
Space group |
C2/c |
P![[1 with combining macron]](https://www.rsc.org/images/entities/char_0031_0304.gif) |
P21/c |
a (Å) |
20.622(8) |
9.0585(18) |
8.1044(16) |
b (Å) |
9.858(2) |
11.245(2) |
16.023(3) |
c (Å) |
19.482(4) |
11.283(2) |
10.137(4) |
α (°) |
90 |
94.55(3) |
90 |
β (°) |
117.55(3) |
108.18(3) |
117.31(2) |
γ (°) |
90 |
93.49(3) |
90 |
V (Å3) |
3511.4(17) |
1084.0(3) |
1169.6(6) |
Z |
8 |
2 |
4 |
Dc (mg m−3) |
1.709 |
1.764 |
2.141 |
μ (mm−1) |
1.436 |
2.488 |
4.117 |
F(000) |
1839 |
568 |
744 |
Collected reflections |
14 819 |
9492 |
9859 |
Unique reflections |
3092 |
3816 |
2055 |
Rint |
0.0637 |
0.0418 |
0.0706 |
R1a [I > 2σ(I)] |
0.0533 |
0.0395 |
0.0550 |
wR2b [all data] |
0.0997 |
0.0825 |
0.1103 |
GOF on F2 |
1.138 |
1.071 |
1.167 |
Δρmax, Δρmin (e Å−3) |
0.83, −0.50 |
0.62, −0.42 |
0.90, −0.47 |
Results and discussion
Structures modulation and comparison
In the synthesis process, as introduction mentioned, we carefully select three different synthetic conditions to modulate the structures: the different metal–ligand ratio, different solvents and auxiliary ligand. In compounds 1 and 2, the synthetic conditions are similar but only the metal–ligand ratio is different. From compound 1 to 2, the amount of Zn2+ ions increases one times, the metal–ligand ratio relative decrease, which reduce the coordination chance for ligand to metal and led to the change of metal coordination modes: the coordination numbers of Zn2+ ions reduce from 6 to 4. As a result, the dimensionalities of the CPs reduce from 3D for compound 1 to 2D for compound 2. Compared compounds 1, 2 with 3, there are two different synthetic conditions to influence the structures. Firstly, it is interesting to note that the organic solvents with different sizes, boiling points and polarities play important roles in inducing different structural aggregates of the three compounds, which not only dramatically influence the different dimensionalities of the compounds, but also allow access to new structures and topologies through inducing the different coordination environments of Zn2+ ions and linking modes of m-pdtz2− ligand. Due mainly to the employment of EtOH solvent with bigger steric hindrance, smaller boiling points and polarities than those in H2O under similar synthetic conditions, distinct framework structures were obtained. By the introducing EtOH in the synthesis system of 3, the vapor pressure in the Teflon lined stainless steel container is increase, which can improve the solubility and reaction rate of the reactants. As a result, the nuclear degree of the Zn2+ ions is increase for forming a binuclear {Zn2} cluster as SBU and further give a 1D rod-shaped Zn chain. Secondly, we introduce the auxiliary ligand in the compounds 1 and 2, namely the rigid long chain-like N-donor 4,4′-bipy, to induce the potential structural transformations, mainly because of its propensity to form voids or frameworks structures as the compounds 1 and 2 displayed. While compound 3 is a 3D compact structure by the introduction of smaller OH− group by accident and without the rigid linear 4,4′-bipy sustaining the framework. The result shows that the choice of different metal-ligand ratio, different solvents and auxiliary ligand is clearly critical in determining the molecular architectures of the CPs and has a significant effect on the final structures.
Structural analysis
Structure of [Zn(m-pdtz)(4,4′-bipy)(H2O)]n (1). Single-crystal structural analysis reveals that 1 crystallizes in the monoclinic space group C2/c and has a 6-connected 3D structural topology constructed from dimeric {Zn2} clusters as SBUs. The basic structural unit of 1 contains one Zn2+ ion, one m-pdtz2− ligand, one 4,4′-bipy ligand and one coordinated H2O molecule. The asymmetric unit and coordination mode of Zn2+ center is shown in Fig. 1a. The Zn2+ ion is coordinated with three μ1-2 coordinated nitrogen atoms originating from three independent m-pdtz2− ligands, two nitrogen atoms deriving from two different 4,4′-bipy ligands, and one terminal H2O molecule to form a hexa-coordinated distorted octahedral geometry. The bond lengths and angels are shown in Table S1.† All m-pdtz2− ligands possess the same tridentate coordination mode (μ1-2,2′ and μ2-2), that is, two adjacent N-donors from one tetrazolate groups (μ1-2,2′) coordinate with two different Zn2+ ions to generate a dimeric {Zn2} cluster and the third N-donor from the other tetrazolate group (μ1-2) coordinates with the third Zn2+ ion from another dimeric {Zn2} cluster. The 4,4′-bipy act only as a bridging ligand to connect two different Zn2+ ions from two distinct dimeric {Zn2} clusters. Based on above coordination modes, all the dimeric {Zn2} clusters as SBUs are linked by the m-pdtz2− and 4,4′-bipy ligands to form a 3D framework (see Fig. 1b).
 |
| Fig. 1 (a) The ball-and-stick view of the coordination environment of Zn2+ in {Zn2} cluster; (b) the 3D framework in 1; (c) the schematic view of the 6-connected topology with the m-pdtz2− ligands as 2-connected nodes for 1; (d) the partial enlarged drawing in order to show the m-pdtz2− ligands uncrossed feature. Codes: blue, N; gray, C; green, Zn; red, O (the hydrogen atoms have been omitted for clarity). | |
From the topological point of view, the dimeric {Zn2} clusters can be simplified as 6-connected nodes that further links the other six dimeric {Zn2} clusters via four m-pdtz2− ligands and four 4,4′-bipy ligands. Since the 4,4′-bipy ligands involved here act only as linear connection, it is thus not necessary to consider them in the topological analysis. Based on this simplification, the overall 3D network of 1 can be rationalized as a new uninodal 6-connected topology with the Schläfli symbol of {44·611} (TD10 = 3595) (see Fig. 1c). In order to better understand the topology, we rationalized the m-pdtz2− ligands as 2-connected nodes which can be clearly seen from their uncrossed feature (see Fig. 1d).19
Structure of [Zn2Cl2(m-pdtz)(4,4′-bipy)]n (2). The single-crystal X-ray diffraction study reveals that 2 crystallizes in the triclinic space group P
. The basic structure of 2 contains a 2D sql layer built from rhombic tetrameric {Zn4} clusters as SBUs. The basic structural unit of 2 contains two Zn2+ ions, one m-pdtz2− ligand, one 4,4′-bipy ligand and one Cl− ion. The asymmetric unit and coordination mode of Zn2+ centers are shown in Fig. 2a. The two Zn2+ ions exhibit the same tetra-coordinated mode but different coordinated environment. They all coordinate with two different nitrogen atoms originating from two independent m-pdtz2− ligands, one nitrogen atom deriving from one 4,4′-bipy ligands, and one terminal Cl− to form distorted tetrahedral geometries. The only difference is the coordinated N location of m-pdtz2− ligands: one Zn2+ ion links to two μ-1 N-donors and the other connects to two μ-3 N-donors. The bond lengths and angels are shown in Table S2.† All m-pdtz2− ligands possess the same quadridentate coordination mode (μ-1,3:1′,3′), i.e., 1,3-N-donor from two tetrazolate groups coordinates with four different Zn2+ ions. Based on this coordination mode, four different Zn2+ ions are linked together by four m-pdtz2− ligands to form a rhombic tetrameric {Zn4} ring as SBU (see Fig. 2b). The {Zn4} rings as SBUs are further linked by other m-pdtz2− and 4,4′-bipy ligands to give a 2D layer structure (see Fig. 2c). If the rhombic {Zn4} rings can be considered as 4-connected nodes linking with other four tetrameric {Zn4} rings via m-pdtz2− ligands and 4,4′-bipy ligands, the 2D framework of 2 can be rationalized as a uninodal 4-connected sql topology with the Schläfli symbol of {44·62} (TD10 = 221) (see Fig. 2d).19
 |
| Fig. 2 (a) The ball-and-stick view of the coordination environment of the two Zn2+ in 2; (b) the rhombic tetrameric {Zn4} ring SBU in 2; (c) the 2D layer structure of 2; (d) the schematic view of the sql topology for 2. Codes: blue, N; gray, C; green, Zn; turquoise, Cl (the hydrogen atoms have been omitted for clarity). | |
Structure of [Zn2(OH)2(m-pdtz)]n (3). Single-crystal X-ray diffraction analysis shows that compound 3 crystallizes in the monoclinic space group P21/c and exhibits a new (4,6)-connected 3D structural topology constructed from rod-shaped 1D Zn-chains as SBUs. In the asymmetric unit of 3, there are two Zn2+ ion centers, two OH− groups and one m-pdtz2− ligand. The two Zn2+ ions exhibit the same tetra-coordinated mode but different coordinated environment (see Fig. 3a). They all coordinate with two different nitrogen atoms originating from two independent m-pdtz2− ligands and two oxygen atoms deriving from two different OH− groups to form distorted tetrahedral geometries. The only difference is the coordinated N location of m-pdtz2− ligands: one Zn2+ ion links to two μ-1 N-donors and the other connects to one μ-1 N-donor and one μ-2 N-donor. The bond lengths and angels are shown in Table S3.† So all the m-pdtz2− ligands adopt the same quadridentate coordination mode (μ-1,1
:
1′,3′), in other words, one tetrazolate group coordinates with two different Zn2+ ions using its 1,1-N-donors and the other tetrazolate group coordinates with the other two Zn2+ ions using its 1,3-N-donors. At the same time, the OH− group links to two different Zn2+ ions to give a binuclear {Zn2} cluster as SBU. Based on this coordination mode, all binuclear {Zn2} clusters are linked by m-pdtz2− ligands to form a 1D rod-shaped Zn chain (see Fig. 3b). The Zn chains are further linked together by other m-pdtz2− and OH− groups to give a 3D framework (see Fig. 3c). From the topological point of view, the binuclear {Zn2} clusters can be abstracted as 6-connected nodes that link with other six binuclear {Zn2} clusters via m-pdtz2− ligands and OH− groups, while the m-pdtz2− ligands can be rationalized as 4-connected nodes linking with four different binuclear {Zn2} clusters. Based on this simplification, the overall 3D network of 3 can be rationalized as a new binodal (4,6)-connected topology with the Schläfli symbol of {44·62}{46·69} (TD10 = 1413) (see Fig. 3d).19
 |
| Fig. 3 (a) The ball-and-stick view of the coordination environment of Zn2+ in {Zn2} cluster; (b) the polyhedral view of 1D rod-shaped Zn-chain; (c) the 3D framework in 3; (d) the schematic view of the (4,6)-connected topology. Codes: blue, N; gray, C; green, Zn; red, O (the hydrogen atoms have been omitted for clarity). | |
By careful analysis we can see that there are several π–π stacking interactions in these three compounds. The face-to-face π–π stacking can be found between aromatic rings. These interactions are characterized by centroid to centroid distances of 3.759(3), 3.797(3), 3.799(3) Å for 1, 3.640(2), 4.065(2) Å for 2 and 3.916(5) Å for 3, respectively. The detailed data are shown in Fig. S7–S9 and Table S1 (ESI†).
Fluorescence properties
The coordination polymers constructed from d10 metal ions and conjugated organic ligands are promising candidates for hybrid photoactive materials with potential applications such as light-emitting diodes (LEDs).20 So the fluorescence properties of free ligand m-H2pdtz, 1, 2 and 3 were investigated in the solid state at room temperature. As shown in Fig. 4, the free ligand m-H2pdtz exhibits an emission maximum at 473 nm, which can be ascribed to the π* → n or π* → π electronic transition,16b while the emission spectra of 1, 2 and 3 all exhibit similar intensities of fluorescent emissions with the maxima appearing at 326 nm, thus exhibiting a large blue shift as compared with free ligand m-H2pdtz.16b In order to understand the nature of these emission bands, we compared the emission spectra of the three compounds and that of free organic ligands. The comparisons reveal that the free 4,4′-bipy ligand exhibits an emission maximum at 437 nm in consistence with that reported in the references,21 while the similar emission intensities and spectroscopic blue shifts of the CPs 1–3 can be tentatively attributed to the cooperative effects of the charge transfer process and intraligand transition of the Zn-modified m-pdtz2− ligands (π* → n or π* → π), as reported for other ZnII CPs with N-donor ligands.22 In other words, when the ligands coordinated to metal ZnII centres, they can effectively increase both the rigidity and conjugation on CPs and then affect the energy loss via a radiationless pathway within the intraligand.23
 |
| Fig. 4 The emission spectra of free ligand m-H2pdtz (black dash line), 1 (black solid line), 2 (red solid line), and 3 (blue solid line) in the solid state at room temperature. | |
The fluorescence decays for 1–3 in the solid state at room temperature (296 K) were also investigated and obeyed double-exponential decay laws as shown in Fig. S11–S13 (ESI†). The fluorescence lifetime values of the three compounds are τ1 = 1.945 μs (93.8%), τ2 = 9.51 μs (6.2%) for 1, τ1 = 0.8847 μs for 2, and τ1 = 0.8031 μs for 3, respectively. The short lifetime due to the 3d104s0 electron configuration of Zn(II) might reduce the radiative lifetime of triplets by increased spin–orbit coupling and the presence of Zn(II) will also facilitate intersystem crossing.24
Conclusions
In conclusion, three new CPs have been constructed by an in situ ditetrazolate-ligand synthesis system involving the Sharpless [2 + 3] cycloaddition reaction between IPN and NaN3 in the presence of Zn2+ ions as Lewis-acid catalysts under hydro/solvothermal conditions. CP 1 exhibits a new 6-connected 3D structural topology constructed from dimeric {Zn2} clusters as SBUs. CP 2 represents a 2D sql structural feature built from rhombic tetrameric {Zn4} rings as SBUs, while CP 3 displays a new (4,6)-connected 3D structural topology constructed from rod-shaped 1D Zn-chains as SBUs. Moreover, the fluorescence properties of the three CPs have also been studied. Further investigations are underway, including the exploration of their other potential properties and an extension of the in situ ditetrazolate synthesis, aiming at synthesizing novel compounds with diverse topological structures and various interesting functions.
Acknowledgements
This work was financially supported by NNSF of China (21421001, 21403116, 21403102, 21271097 and 51303076), and MOE Innovation Team of China (IRT13022). The authors are also obliged to the Tai-Shan Scholar Research Fund of Shandong Province.
Notes and references
-
(a) G. J. Halder, C. J. Kepert, B. Moubaraki, K. S. Murray and J. D. Cashion, Science, 2002, 298, 1762 CrossRef CAS PubMed;
(b) Y. F. Zeng, X. Hu, F. C. Liu and X. H. Bu, Chem. Soc. Rev., 2009, 38, 469 RSC;
(c) T. Liu, Y. J. Zhang, Z. M. Wang and S. Gao, J. Am. Chem. Soc., 2008, 130, 10500 CrossRef CAS PubMed.
-
(a) Y. Cui, S. J. Lee and W. B. Lin, J. Am. Chem. Soc., 2003, 125, 6014 CrossRef CAS PubMed;
(b) D. N. Dybtsev, A. L. Nuzhdin, H. Chun, K. P. Bryliakov, E. P. Talsi, V. P. Fedin and K. Kim, Angew. Chem., Int. Ed., 2006, 45, 916 CrossRef CAS PubMed;
(c) A. M. Shultz, O. K. Farha, J. T. Hupp and S. T. Nguyen, J. Am. Chem. Soc., 2009, 131, 4204 CrossRef CAS PubMed;
(d) M. Yoon, R. Srirambalaji and K. Kim, Chem. Rev., 2012, 112, 1196 CrossRef CAS PubMed.
-
(a) B. Moulton and M. J. Zaworotko, Chem. Rev., 2001, 101, 1629 CrossRef CAS PubMed;
(b) R. J. Hill, D. L. Long, N. R. Champenss, P. Hubberstey and M. Schröder, Acc. Chem. Res., 2005, 38, 335 CrossRef CAS PubMed;
(c) J. R. Li, J. Sculley and H. C. Zhou, Chem. Rev., 2012, 112, 869 CrossRef CAS PubMed;
(d) M. P. Suh, H. J. Park, T. K. Prasad and D. W. Lim, Chem. Rev., 2012, 112, 782 CrossRef CAS PubMed;
(e) S. L. Qiu and G. S. Zhu, Coord. Chem. Rev., 2009, 253, 2891 CrossRef CAS PubMed;
(f) T. L. Hu, H. Wang, B. Li, R. Krishna, H. Wu, W. Zhou, Y. Zhao, Y. Han, X. Wang, W. Zhu, Z. Yao, S. Xiang and B. Chen, Nat. Commun., 2015, 6, 7328 CrossRef CAS PubMed;
(g) Q. Chen, Z. Chang, W. C. Song, H. Song, H. B. Song, T. L. Hu and X. H. Bu, Angew. Chem., Int. Ed., 2013, 52, 11550 CrossRef CAS PubMed;
(h) Y. W. Li, K. H. He and X. H. Bu, J. Mater. Chem. A, 2013, 1, 4186 RSC.
-
(a) P. Horcajada, C. Serre, G. Maurin, N. A. Ramsahye, F. Balas, M. Vallet-Regí, M. Sebban, F. Taulelle and G. Férey, J. Am. Chem. Soc., 2008, 130, 6774 CrossRef CAS PubMed;
(b) C. Y. Sun, C. Qin, C. G. Wang, Z. M. Su, S. Wang, X. L. Wang, G. S. Yang, K. Z. Shao, Y. Q. Lan and E. B. Wang, Adv. Mater., 2011, 23, 5629 CrossRef CAS PubMed;
(c) Z. B. Ma and B. Moulton, Coord. Chem. Rev., 2011, 255, 1623 CrossRef CAS PubMed.
-
(a) A. C. McKinlay, B. Xiao, D. S. Wragg, P. S. Wheatley, I. L. Megson and R. E. Morris, J. Am. Chem. Soc., 2008, 130, 10440 CrossRef CAS PubMed;
(b) Y. Q. Lan, H. L. Jiang, S. L. Li and Q. Xu, Adv. Mater., 2011, 23, 5015 CrossRef CAS PubMed;
(c) Y. J. Cui, Y. F. Yue, G. D. Qian and B. L. Chen, Chem. Rev., 2012, 112, 1126 CrossRef CAS PubMed;
(d) X. L. Qi, R. B. Lin, Q. Chen, J. B. Lin, J. P. Zhang and X. M. Chen, Chem. Sci., 2011, 2, 2214 RSC;
(e) Y. W. Li, J. R. Li, L. F. Wang, B. Y. Zhou, Q. Chen and X. H. Bu, J. Mater. Chem. A, 2013, 1, 495 RSC.
-
(a) D. Zhao, D. J. Timmons, D. Q. Yuan and H. C. Zhou, Acc. Chem. Res., 2011, 44, 123 CrossRef CAS PubMed;
(b) M. Du, C. P. Li, C. S. Liu and S. M. Fang, Coord. Chem. Rev., 2013, 257, 1282 CrossRef CAS PubMed;
(c) G. P. Yang, L. Hou, X. J. Luan, B. Wu and Y. Y. Wang, Chem. Soc. Rev., 2012, 41, 6992 RSC.
-
(a) Y. B. He, B. Li, M. O'Keeffe and B. L. Chen, Chem. Soc. Rev., 2014, 43, 5618 RSC;
(b) Z. J. Lin, J. Lü, M. C. Hong and R. Cao, Chem. Soc. Rev., 2014, 43, 5867 RSC;
(c) W. S. Liu, T. Q. Jiao, Y. Z. Li, Q. Z. Liu, M. Y. Tan, H. Wang and L. F. Wang, J. Am. Chem. Soc., 2004, 126, 2280 CrossRef CAS PubMed;
(d) J. W. Cheng, J. Zhang, S. T. Zheng, M. B. Zhang and G. Y. Yang, Angew. Chem., Int. Ed., 2006, 45, 73 CrossRef CAS PubMed;
(e) L. T. Du, Z. Y. Lu, K. Y. Zheng, J. Y. Wang, X. Zheng, Y. Pan, X. Z. You and J. F. Bai, J. Am. Chem. Soc., 2013, 135, 562 CrossRef CAS PubMed.
-
(a) S. S. Y. Chui, S. M. F. Lo, J. P. H. Charmant, A. G. Orpen and I. D. Williams, Science, 1999, 283, 1148 CrossRef CAS;
(b) O. M. Yaghi, R. Jernigan, H. L. Li, C. E. Davies and T. L. Groy, J. Chem. Soc., Dalton Trans., 1997, 2383 RSC;
(c) M. Eddaoudi, D. B. Moler, H. L. Li, B. L. Chen, T. Reineke, M. O'Keeffe and O. M. Yaghi, Acc. Chem. Res., 2001, 34, 319 CrossRef CAS PubMed;
(d) Q. R. Fang, G. S. Zhu, Z. Jin, Y. Y. Ji, J. W. Ye, M. Xue, H. Yang, Y. Wang and S. L. Qiu, Angew. Chem., Int. Ed., 2007, 46, 6638 CrossRef CAS PubMed.
-
(a) X. M. Zhang, Z. M. Hao, W. X. Zhang and X. M. Chen, Angew. Chem., Int. Ed., 2007, 46, 3456 CrossRef CAS PubMed;
(b) J. A. Zhao, L. W. Mi, J. Y. Hu, H. W. Hou and Y. T. Fan, J. Am. Chem. Soc., 2008, 130, 15222 CrossRef CAS PubMed;
(c) H. Wu, J. Yang, Z. M. Su, S. R. Batten and J. F. Ma, J. Am. Chem. Soc., 2011, 133, 11406 CrossRef CAS PubMed;
(d) W. Q. Lin, J. D. Leng and M. L. Tong, Chem. Commun., 2012, 48, 4477 RSC;
(e) S. S. Chen, M. Chen, S. Takamizawa, P. Wang, G. C. Lv and W. Y. Sun, Chem. Commun., 2011, 47, 4902 RSC;
(f) H. Y. He, D. Collins, F. N. Dai, X. L. Zhao, G. Q. Zhang, H. Q. Ma and D. F. Sun, Cryst. Growth Des., 2010, 10, 895 CrossRef CAS.
-
(a) J. R. Li, Y. Tao, Q. Yu and X. H. Bu, Chem. Commun., 2007, 1527 RSC;
(b) Z. X. Li, T. L. Hu, H. Ma, Y. F. Zeng, C. J. Li, M. L. Tong and X. H. Bu, Cryst. Growth Des., 2010, 10, 1138 CrossRef CAS;
(c) Z. X. Li, J. P. Zhao, E. C. Sanudo, H. Ma, Z. D. Pan, Y. F. Zeng and X. H. Bu, Inorg. Chem., 2009, 48, 11601 CrossRef CAS PubMed;
(d) Z. X. Li, Y. Xu, Y. Zuo, L. Li, Q. H. Pan, T. L. Hu and X. H. Bu, Cryst. Growth Des., 2009, 9, 3904 CrossRef CAS;
(e) Y. W. Li, H. Ma, Y. Q. Chen, K. H. He, Z. X. Li and X. H. Bu, Cryst. Growth Des., 2012, 12, 189 CrossRef CAS.
-
(a) W. T. Liu, J. Y. Li, Z. P. Ni, X. Bao, Y. C. Ou, J. D. Leng, J. L. Liu and M. L. Tong, Cryst. Growth Des., 2012, 12, 1482 CrossRef CAS;
(b) T. L. Hu, Y. Tao, Z. Chang and X. H. Bu, Inorg. Chem., 2011, 50, 10994 CrossRef CAS PubMed;
(c) J. S. Qin, D. Y. Du, W. L. Li, J. P. Zhang, S. L. Li, Z. M. Su, X. L. Wang, Q. Xu, K. Z. Shao and Y. Q. Lan, Chem. Sci., 2012, 3, 2114 RSC;
(d) H. J. Choi, M. Dincă and J. R. Long, J. Am. Chem. Soc., 2008, 130, 7848 CrossRef CAS PubMed;
(e) Z. P. Demko and K. B. Sharpless, J. Org. Chem., 2001, 66, 7945 CrossRef CAS PubMed;
(f) J. Y. Zhang, A. L. Cheng, Q. Yue, W. W. Sun and E. Q. Gao, Chem. Commun., 2008, 847 RSC;
(g) T. Wu, B. H. Yi and D. Li, Inorg. Chem., 2005, 44, 4130 CrossRef CAS PubMed;
(h) J. Tao, Z. J. Ma, R. B. Huang and L. S. Zheng, Inorg. Chem., 2004, 43, 6133 CrossRef CAS PubMed.
-
(a) D. H. Liu, T. F. Liu, Y. P. Chen, L. F. Zou, D. W. Feng, K. C. Wang, Q. Zhang, S. Yuan, C. L. Zhong and H. C. Zhou, J. Am. Chem. Soc., 2015, 137, 7740 CrossRef CAS PubMed;
(b) D. X. Xue, Y. Belmabkhout, O. Shekhah, H. Jiang, K. Adil, A. J. Cairns and M. Eddaoudi, J. Am. Chem. Soc., 2015, 137, 5034 CrossRef CAS PubMed;
(c) Q. P. Lin, T. Wu, S. T. Zheng, X. H. Bu and P. Y. Feng, J. Am. Chem. Soc., 2012, 134, 784 CrossRef CAS PubMed;
(d) A. Demessence, D. M. D'Alessandro, M. L. Foo and J. R. Long, J. Am. Chem. Soc., 2009, 131, 8784 CrossRef CAS PubMed.
-
(a) H. C. Hu, X. M. Kang, C. S. Cao, P. Cheng and B. Zhao, Chem. Commun., 2015, 51, 10850 RSC;
(b) F. Wang, H. R. Fu, Y. Kang and J. Zhang, Chem. Commun., 2014, 50, 12065 RSC;
(c) X. M. Zhang, J. Lv, F. Ji, H. S. Wu, H. J. Jiao and P. R. Schleyer, J. Am. Chem. Soc., 2011, 133, 4788 CrossRef CAS PubMed;
(d) D. C. Zhong, M. Meng, J. Zhu, G. Y. Yang and T. B. Lu, Chem. Commun., 2010, 46, 4354 RSC.
-
(a) X. M. Chen and M. L. Tong, Acc. Chem. Res., 2007, 40, 162 CrossRef CAS PubMed;
(b) X. M. Zhang, Coord. Chem. Rev., 2005, 249, 1201 CrossRef CAS PubMed;
(c) H. Zhao, Z. R. Qu, H. Y. Ye and R. G. Xiong, Chem. Soc. Rev., 2008, 37, 84 RSC;
(d) J. P. Zhang and X. M. Chen, Chem. Commun., 2006, 1689 RSC.
-
(a) X. M. Zhang, M. L. Tong and X. M. Chen, Angew. Chem., Int. Ed., 2002, 41, 1029 CrossRef CAS;
(b) S. Hu, J. C. Chen, M. L. Tong, B. Wang, Y. X. Yan and S. R. Batten, Angew. Chem., Int. Ed., 2005, 44, 547 Search PubMed;
(c) R. G. Xiong, X. Xue, H. Zhao, X. Z. You, B. F. Abrahams and Z. L. Xue, Angew. Chem., Int. Ed., 2002, 41, 3800 CrossRef CAS;
(d) X. Xue, X. S. Wang, L. Z. Wang, R. G. Xiong, B. F. Abrahams, X. Z. You, Z. L. Xue and C. M. Che, Inorg. Chem., 2002, 41, 6544 CrossRef CAS PubMed.
-
(a) G. E. Kostakis, G. Abbas, C. E. Anson and A. K. Powell, CrystEngComm, 2009, 11, 82 RSC;
(b) C. Jiang, Z. P. Yu, C. Jiao, S. J. Wang, J. M. Li, Z. Y. Wang and Y. Cui, Eur. J. Inorg. Chem., 2004, 4669 CrossRef CAS PubMed;
(c) T. P. Hu, L. J. Liu, X. L. Lv, X. H. Chen, H. Y. He, F. N. Dai, G. P. Zhang and D. F. Sun, Polyhedron, 2010, 29, 296 CrossRef CAS PubMed;
(d) J. Lach, A. P. Mosalkova, S. V. Voitekhovich, P. N. Gaponik and B. Kersting, Polyhedron, 2013, 49, 183 CrossRef CAS PubMed.
-
(a) G. M. Sheldrick, SHELXL97, Program for Crystal Structure Refinement, University of Göttingen, Göttingen, Germany, 1997 Search PubMed;
(b) G. M. Sheldrick, SHELXS97, Program for Crystal Structure Solution, University of Göttingen, Göttingen, Germany, 1997 Search PubMed.
- ESI†.
- V. A. Blatov, TOPOS, A multipurpose Crystallochemical Analysis with the Program Package, Samara State University, Russia, 2004 Search PubMed.
-
(a) L. P. Zhang, J. F. Ma, J. Yang, Y. Y. Pang and J. C. Ma, Inorg. Chem., 2010, 49, 1535 CrossRef CAS PubMed;
(b) W. L. Liu, L. H. Ye, X. F. Liu, L. M. Yuan, J. X. Jiang and C. G. Yan, CrystEngComm, 2008, 10, 1395 RSC;
(c) R. H. Wang, L. Han, F. L. Jiang, Y. F. Zhou, D. Q. Yuan and M. C. Hong, Cryst. Growth Des., 2005, 5, 129 CrossRef CAS.
- J. L. Song, H. H. Zhao, J. G. Mao and K. R. Dunbar, Chem. Mater., 2004, 16, 1884 CrossRef CAS.
-
(a) S. Wang, Coord. Chem. Rev., 2001, 215, 79 CrossRef CAS;
(b) Y. Q. Xu, D. Q. Yuan, B. L. Wu, L. Han, M. Y. Wu, F. L. Jiang and M. C. Hong, Cryst. Growth Des., 2006, 6, 1168 CrossRef CAS.
-
(a) B. L. Wu, C. P. Liu, D. Q. Yuan, F. L. Jiang and M. C. Hong, Cryst. Growth Des., 2008, 8, 3791 CrossRef CAS;
(b) E. C. Yang, H. K. Zhao, B. Ding, X. G. Wang and X. J. Zhao, Cryst. Growth Des., 2007, 7, 2009 CrossRef CAS.
-
(a) S. K. Dutta and M. W. Perkovic, Inorg. Chem., 2002, 41, 6938 CrossRef CAS PubMed;
(b) Y. Gong, H. F. Shi, P. G. Jiang, W. Hua and J. H. Lin, Cryst. Growth Des., 2014, 14, 649 CrossRef CAS.
Footnote |
† Electronic supplementary information (ESI) available: CCDC 1407193–1407195. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra15576b |
|
This journal is © The Royal Society of Chemistry 2015 |
Click here to see how this site uses Cookies. View our privacy policy here.